iofetamine has been researched along with Parkinson Disease, Secondary in 1 studies
Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, M | 1 |
| Okuda, B | 1 |
| Tomino, Y | 1 |
| Tachibana, H | 1 |
| Sugita, M | 1 |
1 review available for iofetamine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[A case of posttraumatic parkinsonism].
Topics: Amphetamines; Craniocerebral Trauma; Humans; Iodine Radioisotopes; Iofetamine; Male; Middle Aged; Pa | 1991 |